已發(fā)表論文：（*為通訊作者） （1）Zhixiong Cai#, Xiaoping Su#, Liman Qiu#, Zhenli Li#, Xiaolou Li, Xiuqing Dong, Fuqun Wei,Yang Zhou, Liuping Luo, Geng Chen, Hengkai Chen, Yingchao Wang, Yongyi Zeng*, Xiaolong Liu*. Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion. Molecular Cancer, 2021, 20(1):164.（IF:41.444，中科院一區(qū)） （2）Naishun Liao#, Lichao Su#, Yanbing Cao, Liman Qiu, Rong Xie, Fang Peng, Zhixiong Cai, Xiaolong Liu, Jibin Song*, and Yongyi Zeng*. Tracking Cell Viability for Adipose-Derived Mesenchymal Stem Cell-Based Therapy by Quantitative Fluorescence Imaging in the Second Near-Infrared Window. ACS Nano. 2022, 16(2):2889-2900（IF:18.027，中科院一區(qū)） （3）Yunhao Wang, Qingfu Zhao, Binyu Zhao, Youshi Zheng, Qiuyu Zhuang, Naishun Liao, Peiyuan Wang, Zhixiong Cai, Da Zhang*, Yongyi Zeng*, Xiaolong Liu*.Remodeling Tumor-Associated Neutrophils to Enhance Dendritic Cell-Based HCC Neoantigen Nano-Vaccine Efficiency. Adv Sci, 2022, 2105631.（IF:16.806，中科院一區(qū)） （4）Da Zhang#, Ziguo Lin#, Youshi Zheng, Jibin Song, Juan Li, Yongyi Zeng*, Xiaolong Liu*. Ultrasound-Driven Biomimetic Nanosystem Suppresses Tumor Growth and Metastasis through Sonodynamic Therapy, CO Therapy, and Indoleamine 2,3-Dioxygenase Inhibition.ACS Nano, 2020, 14（7）:8985-8999.（IF:14.588，中科院一區(qū)） （5）Yanni Wua#, Lei Ding#, Cheng Zheng, Hongsheng Li, Ming Wu, Yupeng Sun,Xiaolong Liu, Xiaolong Zhang*, Yongyi Zeng*. Acta Biomaterialia, 2022,153:419-430.（IF:10.633，中科院一區(qū)） （6）Yanbing Cao, De Wei, Lixia Yang, Zijin Luo, Peiwen Yu, Hao Li, Cao Zhang, Xiaolong Liu, Fengshou Wu*, Ming Wu*, and Yongyi Zeng*. Nanoplatform Self-Assembly from Small Molecules of Porphyrin Derivatives for NIR-II Fluorescence Imaging Guided Photothermal-Immunotherapy. Advanced Healthcare Materials, 2022, 11(11)e2102526（IF:11.092，中科院一區(qū)） （7）Yongyi Zeng#, Wei Zhang#, Zhenli Li#, Youshi Zheng, Yingchao Wang, Geng Chen, Liman Qiu, Kun Ke, Xiaoping Su, Zhixiong Cai, Jingfeng Liu*, Xiaolong Liu*. Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report.Journal for immunotherapy of cancer,2020,8(1)：e000217.（IF:9.913，中科院一區(qū)） （8）Qiao Ke#, Lei Wang#, Ziguo Lin#, Jianying Lou, Shuguo Zheng, Xinyu Bi, Jianming Wang, Wei Guo, Fuyu Li, Jian Wang, Yamin Zheng, Jingdong Li, Shi Cheng, Weiping Zhou, Yongyi Zeng*.Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From China. Front Oncol, 2021, 11:585808.（IF: 6.244，中科院二區(qū)） （9）Jun Fu#, Qinjunjie Chen#, Yuyan Yu#, Wuyi You, Zongren Ding, Yuzhen Gao, Haitao Li*, Yongyi Zeng*.Impact of portal hypertension on short-and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis. Cancer Medicine, 2021, 10(20):6985-6997.（IF:4.452，中科院三區(qū)） （10）Hongzhi Liu#, Lianku Lin#, Ziguo Lin#, Yifan Chen#, Qizhen Huang, Lei Ding, Jianying Lou, Shuguo Zheng, Xinyu Bi, Jianming Wang, Wei Guo, Fuyu Li, Jian Wang, Yamin Zheng, Jingdong Li, Shi Cheng, Weiping Zhou, Zhangjun Cheng, Yongyi Zeng*. Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma:a multicenter study. BMC Cancer, 2021,10:6985-6997.（IF:4.43，中科院三區(qū)） 授權(quán)發(fā)明專利： （1）劉小龍，劉景豐，張達(dá)，曾永毅，用于腫瘤早期診斷與光學(xué)治療的多功能納米膠束及其應(yīng)用，2015.07.21，2018.05.29，中國，ZL201510429203.7 （2）劉景豐，曾永毅，劉小龍，張曉龍，鄭愛仙，廖乃順，一種檢測galectin-4的熒光酶聯(lián)免疫分析方法，2016.07.11，2018.03.06，中國，ZL201610539941.1 （3）劉景豐，劉小龍，林心怡，曾永毅，一種光響應(yīng)性氧化硅納米載體及其制備方法，2017.08.03，2020.06.23，ZL201710655234.3 （4）張達(dá)，曾永毅，劉景豐，劉小龍，黑磷量子點(diǎn)/鉑雜化介孔二氧化硅納米顆粒及制備方法和應(yīng)用，2018.11.13，2021.08.17，ZL201811343125.9 （5）劉小龍，劉景豐，鄭愛仙，曾永毅，一種可響應(yīng)PH的水溶性檢測探針及其制備與應(yīng)用，2019.04.30，2022.04.29，ZL201910360230.1 |
